CVS Caremark (CVS) Reports In-Line Q4 EPS; Boosts Q112 EPS, Guides FY12 EPS
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $93.02 -0.67%
Financial Fact:
Operating profit: 2.82B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Operating profit: 2.82B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) reported Q4 EPS of $0.89, in-line with the analyst estimate of $0.89. Revenue for the quarter came in at $28.3 billion versus the consensus estimate of $28.12 billion.
CVS Caremark sees FY2012 EPS of $3.18-$3.28, versus the consensus of $3.24.
CVS Caremark sees Q1 2012 EPS of $0.61-$0.63, versus prior guidance of $0.58-$0.60 and the consensus of $0.61.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
CVS Caremark sees FY2012 EPS of $3.18-$3.28, versus the consensus of $3.24.
CVS Caremark sees Q1 2012 EPS of $0.61-$0.63, versus prior guidance of $0.58-$0.60 and the consensus of $0.61.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
